FDA says yes to radiation therapy firm's nTRAK patient positioning system:
This article was originally published in Clinica
Executive Summary
North American Scientific has received US FDA 510(k) market clearance for its nTRAK stereotactic image guidance system, which is used to position and monitor patients during radiation therapy treatments for head and neck cancers. The system uses an optical camera and fiducial markers attached to a customised bite block to assure that a patient is positioned reproducibly within required tolerances throughout a course of radiation therapy treatments. The Chatsworth, California firm said it expected sales of nTRAK to begin in the fourth quarter of fiscal 2005.